Picture EBD Group BIO-Europe 2023 Munich BEU23 650x100px

News > All

Please find below news from the United Kingdom (Great Britain) and the Republic of Ireland as well as about organisations from these countries.

Total search results: 2762 | Ordered by Date (descending)
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
eXmoor Pharma Concepts Ltd.. (5/30/23). "Press Release: eXmoor Pharma Completes $35 Million Series A to Expand Cell and Gene Therapy Manufacturing Capabilities". Bristol. 2023-05-30
ElevateBio, LLC. (5/24/23). "Press Release: ElevateBio Announces $401 Million Series D Financing to Further Accelerate Growth". Waltham, MA. 2023-05-24
Renegade Therapeutics, Inc.. (5/23/23). "Press Release: ReNAgade Therapeutics Launches with Over $300 Million in Series A Financing to Unlock the Limitless Potential of RNA Medicine". Cambridge, MA. 2023-05-23
Council of European BioRegions (CEBR). (5/17/23). "Press Release: CEBR Appoints New President and Vice-President at Its Annual Meeting 2023". Stuttgart. 2023-05-17
Closed Loop Medicine Ltd.. (5/17/23). "Press Release: Closed Loop Medicine and Pharmanovia Enter a Co-development Partnership for Precision Medicine Combination Therapeutics". London & Basildon. 2023-05-17
H.E.L. Group. (5/16/23). "Press Release: H.E.L Group Makes Senior Appointments as It Continues to Scale Globally". London. 2023-05-16
Dualyx N.V.. (5/15/23). "Press Release: Dualyx Raises €40 Million to Progress Treg Therapies for Autoimmune Diseases into the Clinic". Ghent. 2023-05-15
Evonetix Ltd.. (5/15/23). "Press Release: Evonetix Delivers First Chip-synthesized DNA to the University of Cambridge". 2023-05-15
Uniqure N.V.. (5/15/23). "Press Release: Uniqure Announces Sale of Royalty Interest in Hemgenix for up to $400 Million". Lexington, MA & Amsterdam. 2023-05-15
Nido Biosciences, Inc.. (5/15/23). "Press Release: Nido Biosciences Emerges as Clinical Stage Company Raising $109 Million to Advance Treatments for Debilitating Neurological Diseases". Watertown, MA. 2023-05-15
Evotec SE. (5/12/23). "Press Release: Evotec Publishes Annual Report 2022 and Quarterly Statement for Q1 2023". Hamburg. 2023-05-12
Bicycle Therapeutics plc. (5/1023). "Press Release: Bayer and Bicycle Therapeutics Enter Strategic Collaboration for Development of Novel Targeted Radionuclide Therapies in Oncology". Berlin, Cambridge & Boston, MA. 2023-05-10
Ascend Gene and Cell Therapies Ltd.. (5/9/23). "Press Release: Gene and Cell Therapy Manufacturing Specialist Ascend Launches with over $130M of Funding as Expert Teams Merge". London. 2023-05-09
Bruker Corporation. (5/8/23). "Press Release: Bruker Announces Acquisition of Zontal to Advance the Digital Laboratory Transformation and Integrated Biopharma Data Solutions". Billerica, MA. 2023-05-08
Transgene S.A.. (5/5/23). "Press Release: Transgene Announces New Leadership Structure to Accelerate the Development of its Innovative Immunotherapy Portfolio". Strasbourg. 2023-05-05
Alia Therapeutics S.r.l.. (5/5/23). "Press Release: Alia Therapeutics Names Letizia Goretti as Chief Executive Officer". Milan. 2023-05-05
MicrofluidX Ltd.. (5/2/23). "Press Release: MicrofluidX and Immatics Working Together on Automated End-to-End Bioprocessing for TCR-T Therapies". Stevenage & Houston, TX. 2023-05-02
Evommune, Inc.. (4/26/23). "Press Release: Evommune Closes $50 Million Series B Financing to Advance Broad Pipeline of Therapies to Treat Chronic Inflammatory Diseases". Palo Alto, CA. 2023-04-26
Ariceum Therapeutics GmbH. (4/18/23). "Press Release: Ariceum Therapeutics Announces Extension of Series A Financing to EUR 47.75M to Advance its Next Generation Radiopharmaceutical Clinical Pipeline". Berlin. 2023-04-18
Complement Therapeutics GmbH. (4/17/23). "Press Release: Complement Therapeutics Secures €72 Million in Series A Financing to Advance Novel Therapies Targeting Complement-Mediated Diseases". Munich. 2023-04-17
Alentis Therapeutics AG. (4/13/23). "Press Release: Alentis Therapeutics Closes $105 Million Series C Funding to Advance Transformational Medicines for Claudin-1". Basel. 2023-04-13
Vitarka Therapeutics Ltd.. (4/6/23). "Press Release: UK Biotech Start-up Secures £1.27M to Revolutionise Intracellular Drug Delivery through Tumour Targeted Technology". 2023-04-06
Syncona Ltd.. (4/5/23). "Press Release: Syncona Appoints Roel Bulthuis as Managing Partner". 2023-04-05
AMSilk GmbH. (4/4/23). "Press Release: AMSilk Announces Extension of Series C Financing to EUR 54M". Munich. 2023-04-04
Mosaic Therapeutics Ltd.. (4/4/23). "Press Release: Mosaic Therapeutics Closes $28m Series A Funding and Appoints Brian Gladsden as CEO". Cambridge. 2023-04-04
Biocartis Group N.V.. (4/4/23). "Press Release: Biocartis and APIS Assay Technologies Sign Collaboration to Develop and Commercialise a Breast Cancer Subtyping Test on the Idylla Platform". Mechelen. 2023-04-04
Adcendo ApS. (4/4/23). "Press Release: Adcendo ApS Announces Extension of Series A Financing to 82M EUR to Ensure Broad Development of its First-in-class ADC Pipeline". Copenhagen. 2023-04-04
Endpoints Company. (4/3/23). "Press Release: Financial Times Acquires Majority Stake in Endpoints News". Lawrence, KS. 2023-04-03
Sofinnova Partners. (3/28/23). "Press Release: BioCorteX Raises $5 Million in Funding Led by Sofinnova Partners and Hoxton Ventures to Unlock Drug-bacteria Interactions". London. 2023-03-28
SR One Capital Management. (3/27/23). "Press Release: SR One Closes Second Venture Fund at $600M". Redwood City, CA & London. 2023-03-27
Macomics Ltd.. (3/23/23). "Press Release: Macomics and Ono Pharmaceutical Partner to Discover and Develop Macrophage-targeting Antibody Therapy". 2023-03-23
Aldena Therapeutics Inc.. (3/16/23). "Press Release: Aldena Therapeutics Accelerates Its Novel and Disruptive Approach to Immuno-Dermatology". Boston, MA. 2023-03-16
Owlstone Medical Ltd.. (3/15/23). "Press Release: Owlstone Medical Enters Partnership with Bicycle Therapeutics for the Development of Antigen-Targeted EVOC Probes for Early Cancer Detection". Cambridge. 2023-03-15
MorphoSys AG. (3/14/23). "Press Release: Lucinda Crabtree to Join MorphoSys as Chief Financial Officer". Planegg. 2023-03-14
CN Bio Innovations Ltd.. (3/14/23). "Press Release: CN Bio Appoints Deepak Singh as Vice President of Sales and Marketing". Cambridge. 2023-03-14
Teitur Trophics ApS. (3/14/23). "Press Release: Teitur Trophics Raises EUR 28M in Series A Financing to Advance the Development and Treatment for Neurodegenerative Diseases". Aarhus. 2023-03-14
Exscientia plc. (3/14/23). "Press Release: Exscientia Announces Expansion of its Precision Oncology Pipeline". Oxford. 2023-03-14
UCB S.A.. (3/9/23). "Press Release: UCB’s Board of Directors Appoints Jonathan Peacock as New Chair". Brussels. 2023-03-09
UCB S.A.. (3/9/23). "Press Release: Cancer Research UK Signs Multi-Project Collaboration with UCB to Advance Oncology Antibody Candidates". Brussels & London. 2023-03-09
Personalis, Inc.. (3/7/23). "Press Release: Personalis Selected for Clinical Research After Successful Evaluation of Whole Genome-Based Molecular Residual Disease Assay". Fremont, CA. 2023-03-07
Exscientia plc. (3/7/23). "Press Release: Exscientia Announces Collaboration with Charité to Advance Development of Precision Medicine Platform". Oxford & Berlin. 2023-03-07
Adaptimmune Therapeutics plc. (3/6/23). "Press Release: Adaptimmune and TCR2 Therapeutics Announce Strategic Combination to Create a Preeminent Cell Therapy Company for Solid Tumors". Philadeliphia, PA, Oxford & Canbridge, MA. 2023-03-06
Oculis Holding AG. (3/3/23). "Press Release: Oculis Announces US Public Listing on NASDAQ". Lausanne & Zug. 2023-03-03
MorphoSys AG. (3/2/23). "Press Release: MorphoSys Stops Work and Operations on Pre-Clinical Research Programs". Planegg. 2023-03-02
Antiverse Ltd.. (3/1/23). "Press Release: Antiverse Raises Funding and Demonstrates Therapeutic Antibody Identification with AI-driven Drug Discovery platform". Cardiff. 2023-03-01
Five Alarm Bio Ltd.. (2/27/23). "Press Release: Five Alarm Bio, Focused on Minimising the Effects of Aging in Humans, Raises Seed Investment". Cambridge. 2023-02-27
AdBio Partners S.A.S.. (2/23/23). "Press Release: AdBio Partners Appoints Geoffroy de Ribains as Managing Partner". Paris. 2023-02-23
Cerevance. (2/23/23). "Press Release: Cerevance Expands Series B Financing with Additional $51 Million". Boston, MA. 2023-02-23
eXmoor Pharma Concepts Ltd.. (2/22/23). "Press Release: eXmoor Pharma and Vaccine Developer Imophoron Sign Process Development Partnership". Bristol. 2023-02-22
Consilium Strategic Communications Ltd.. (2/20/23). "Press Release: Consilium Strategic Communications Expands International Presence in US and Europe with Two Senior Strategic Advisor Appointments". London. 2023-02-20
High-Tech Gründerfonds Management GmbH. (2/17/23). "Press Release: Selfapy Brings a Strategic Investor on Board". Berlin. 2023-02-17
Targovax ASA. (2/16/23). "Press Release: Targovax Announces Financing of up to NOK 300m Over Three Years to Advance Its Clinical Cancer Programs and Pre-clinical Circular RNA platform". Oslo. 2023-02-16
Lift BioSciences Ltd.. (2/16/23). "Press Release: LIfT BioSciences and Minaris Regenerative Medicine Enter into a Manufacturing Partnership". London & Munich. 2023-02-16
Panekès Partners SGR S.p.A.. (2/16/23). "Press Release: Panakès Partners Announces the Final Closing of the »Purple« Fund at 175 Million Euros". Milan. 2023-02-16
Maxion Therapeutics Ltd.. (2/15/23). "Press Release: Maxion Therapeutics’ $16 Million Series A to Drive Antibody Development for Previously Untreatable Ion Channel and GPCR-driven Diseases". Cambridge. 2023-02-15
Biotage AB. (2/15/23). "Press Release: Biotage Strengthens Its Position as a Global Chromatography Leader with the Transformative Acquisition of Astrea Bioseparations". Uppsala. 2023-02-15
Charles River Laboratories International, Inc.. (2/15/23). "Press Release: Charles River and Purespring Therapeutics Announce Gene Therapy Manufacturing Collaboration". Wilmington, MA. 2023-02-15
Replay Holdings LLC. (2/14/23). "Press Release: KKR-backed Replay and MD Anderson Form New Product Company Syena to Pioneer First-in-class TCR-NK Cell Therapy". San Diego, CA, London & Houston, TX. 2023-02-14
Cydar Ltd.. (2/13/23). "Press Release: Cydar Medical Raises $11.5M (£9.3M) in Series A Funding Round". Cambridge. 2023-02-13
Bayer AG. (2/13/23). "Press Release: Bayer Completes Acquisition of Blackford Analysis Ltd. [not intended for U.S. and UK Media]". Berlin. 2023-02-13
Freeline Therapeutics Holdings plc. (2/10/23). "Press Release: Freeline Announces Closing of Sale of Its CMC-focused German Subsidiary". London. 2023-02-10
BrainRepair UG. (2/8/23). "Press Release: Breakthrough – EUR 50 Million Investment for Start-up BrainRepair UG". Bochum. 2023-02-08
H.E.L. Group. (2/8/23). "Press Release: H.E.L Group appoints Allen Wang as General Manager of H.E.L China". London. 2023-02-08
Evonetix Ltd.. (2/7/23). "Press Release: Evonetix Closes $24 Million USD (£20 Million) Financing. Oversubscribed Round Led by Foresite Capital". Cambridge. 2023-02-07
Oxford Science Enterprises plc. (2/7/23). "Press Release: Oxford Science Enterprises Strengthens Life Sciences Investment Team with Appointment of Sanne de Jongh as Partner". Oxford. 2023-02-07
APIS Assay Technologies Ltd.. (2/2/23). "Press Release: Clickmer Systems Receives €1.1m Grant to Deliver Innovative Diagnostic Platform for Fast Pandemic Responsiveness". 2023-02-02
Patient Square Capital L.P.. (2/1/23). "Press Release: Patient Square Capital Announces Record $3.9 Billion Inaugural Fund". Menlo Park, CA. 2023-02-01
Capitainer AB. (1/30/23). "Press Release: Capitainer Announces Collaboration with AstraZeneca". Stockholm. 2023-01-30
BioIndustry Assocation (BIA). (1/25/23). "Press Release: BIA Announces New Appointments to the BIA Board". 2023-01-25
DeuterOncology N.V.. (1/19/23). "Press Release: DeuterOncology Closes €5.65M Series A Financing Round". Liège. 2023-01-19
Bayer AG. (1/18/23). "Press Release: Bayer Acquires Blackford Analysis Ltd. Bolstering the company’s Position in Digital Medical Imaging [not intended for U.S. and UK Media]". Berlin. 2023-01-18
Green Bioactives Ltd.. (1/17/23). "Press Release: Green Bioactives Appoints Experienced Biotech Leaders Chris Meaney and Andy Hall-Ponselé to Expand Senior Management Team". Edinburgh. 2023-01-17
BioGeneration Ventures B.V.. (1/17/23). "Press Release: BGV Appoints Jaap de Bruin as FIRST Fund Investment Manager and Promotes Rianne Ellenbroek to Principal". Amsterdam. 2023-01-17
Optibrium Ltd.. (1/17/23). "Press Release: Optibrium Appoints Steve Yemm as Chief Commercial Officer". Cambridge. 2023-01-17
Vésale Bioscience. (1/17/22). "Press Release: Vésale Bioscience Receives €1.8M Grant from European Innovation Council for PhageDiag Project". Namur. 2023-01-17
AstraZeneca plc. (1/16/23). "Press Release: Acquisition of Neogene Therapeutics Completed". 2023-01-16
BioNTech SE. (1/10/23). "Press Release: BioNTech to Acquire InstaDeep to Strengthen Pioneering Position in the Field of AI-powered Drug Discovery, Design and Development". Mainz & London. 2023-01-10
Astrea Bioseparations. (1/9/23). "Press Release: Astrea Bioseparations Acquires Delta Precision Ltd, a Leading Manufacturer of Chromatography Columns for Biomanufacturing". 2023-01-09
Proteros Biostructures GmbH. (1/9/23). "Press Release: Proteros Receives Minority Investment from Private Equity Firm Inflexion". Martinsried. 2023-01-09
AstraZeneca plc. (1/9/23). "Press Release: AstraZeneca to Acquire CinCor Pharma to Strengthen Cardiorenal Pipeline". 2023-01-09
Chiesi Farmaceutici S.p.A.. (1/8/23). "Press Release: Chiesi Farmaceutici S.p.A. to Acquire Amryt Pharma Plc". Parma, Boston, MA & Dublin. 2023-01-08
CureVac N.V.. (1/6/23). "Press Release: CureVac Announces Positive Data on Joint COVID-19 and Flu mRNA Vaccine Development Programs". Tübingen & Boston, MA. 2023-01-06
BioNTech SE. (1/6/23). "Press Release: BioNTech Announces Strategic Partnership with UK Government to Provide up to 10,000 Patients with Personalized mRNA Cancer Immunotherapies by 2030". Mainz. 2023-01-06
Akamis Bio Ltd.. (1/5/23). "Press Release: Akamis Bio Announces $30 Million Financing, Provides Clinical Program Update and Relaunches with Name Change from PsiOxus Therapeutics". Cambridge, MA & Oxford. 2023-01-05
Actimed Therapeutics Ltd.. (1/4/23). "Press Release: Actimed Therapeutics Successfully Closes Second Tranche of £10m Seed Financing". London. 2023-01-04
Stablepharma Ltd.. (12/23/22). "Press Release: Stablepharma Closed Series A Funding round of $6.4m to Progress Fridge-free Vaccines and mRNA/LNP Stabilisation Technologies". 2022-12-23
Oxford Biomedica plc. (12/22/22). "Press Release: Oxford Biomedica to Present at 41st Annual J.P. Morgan Healthcare Conference". Seattle, WA. 2022-12-22
Stifel Financial Corporation. (12/22/22). "Press Release: Stifel to Acquire Torreya Partners". St. Louis, MO. 2022-12-22
Merck & Co., Inc.. (12/21/22). "Press Release: Lynparza (olaparib) in Combination With Abiraterone and Prednisone or Prednisolone Approved in the EU as Treatment for Certain Patients With Metastatic Castration-Resistant Prostate Cancer". Rahway, NJ. 2022-12-21
Ethris GmbH. (12/21/22). "Press Release: Ethris Announces Collaboration with DIOSynVax and CEPI to Develop a Broadly Protective mRNA Vaccine Against Betacoronaviruses". Munich. 2022-12-21
CN Bio Innovations Ltd.. (12/19/22). "Press Release: CN Bio Appoints Dr Paul Brooks as Chief Executive Officer". Cambridge. 2022-12-19
Lift BioSciences Ltd.. (12/19/22). "Press Release: Lift BioSciences Investors Increase Investment in Lift and Johnson and Johnson Welcomes Lift into JLABS". London. 2022-12-19
Minervax ApS. (12/15/22). "Press Release: Minervax Announces 72M EUR Financing to Advance Development of Novel Vaccine against Group B Streptococcus". Copenhagen. 2022-12-15
Ori Biotech Ltd.. (12/15/22). "Press Release: Ori Biotech and Inceptor Bio Partner to Accelerate Solid Tumor Cell Therapy Access". London & Morrisville, NC. 2022-12-15
PhoreMost Ltd.. (12/14/22). "Press Release: PhoreMost and ThinkCyte Collaborate to Advance AI Based Drug Discovery". Cambridge. 2022-12-14
PrecisionLife Ltd.. (12/14/22). "Press Release: PrecisionLife Enters into a Multi Target R&D Collaboration Agreement with Ono Pharmaceutical". Oxford. 2022-12-14
Storm Therapeutics Ltd.. (12/14/22). "Press Release: Storm Therapeutics Announces Closing of USD $30M Series B Financing". Cambridge. 2022-12-14
Oxford Biomedica plc. (12/14/22). "Press Release: Oxford Biomedica Solutions Forms New Partnerships with Three Biotechnology Companies". Oxford. 2022-12-14
BehaVR, Inc.. (12/13/22). "Press Release: BehaVR and OxfordVR Combine and Raise Series B to Create Largest VR Delivery Platform for Evidence-Based Digital Therapeutics". Nashville, TN & Oxford. 2022-12-13
Green Bioactives Ltd.. (12/13/22). "Press Release: Green Bioactives Completes £2.6m Seed Financing to Advance Its Sustainable Plant Products Biomanufacturing Platform". Edinburgh. 2022-12-13
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28  next pagenext page


Picture EasyFairs Connect in Pharma 2023 Geneva Speakers 650x200px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at (life sciences in German-speaking Europe) and (worldwide mass spectrometry)


Picture EBD Group ASCO 2023 Annual Meeting Connecting Cancer 650x300px

» top